3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
52
NIH
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Neoplasms
1
Interventions
Cryotherapy
2
relugolix
1
nilutamide
1
histrelin
1
enzalutamide
1
capivasertib
1
bicalutamide
1
apalutamide
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abiraterone
1
Triptorelin Pamoate
1
Surveys and Questionnaires
1
Prednisone
1
Nutritional Status
1
Methylprednisolone
1
Leuprolide
1
Hydroxychloroquine
1
Goserelin
1
Golytely
1
Flutamide
1
Exercise
1
Ethiodized Oil
1
Endoscopy, Digestive System
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Cystoscopy
1
Cryosurgery
1
Androgen Antagonists
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Exercise
×
90 days
×
Clear all
NCT05912257
2026-05-20
NOSH
VA Office of Research and Development
Phase NA
Recruiting
188 enrolled